Literature DB >> 22564711

Mephedrone (4-methylmethcathinone): what is new in our understanding of its use and toxicity.

David M Wood1, Paul I Dargan.   

Abstract

Mephedrone (4-methylmethcathinone) is a synthetic cathinone that has been used as a recreational drug in Europe and elsewhere in the world since 2007. In addition to published scientific papers there are a number of different data sources available which provide information on the sources, availability and prevalence of use of mephedrone. Whilst there are no formal human studies to determine the acute toxicity of mephedrone, there is a range of different levels of data available which describe the acute toxicity of mephedrone. These include user Internet discussion fora, sub-population level surveys of user previous experiences of acute toxicity and individual case reports and case series of toxicity related to both self-reported and analytically confirmed mephedrone use. In this review article we describe how through the process of data triangulation using a combination of these different sources, it is possible to develop an understanding of the acute toxicity of mephedrone. This demonstrates that mephedrone has a pattern of acute toxicity that is similar to other stimulant drugs such as MDMA, amphetamine and cocaine.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22564711     DOI: 10.1016/j.pnpbp.2012.04.020

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  13 in total

Review 1.  The preclinical pharmacology of mephedrone; not just MDMA by another name.

Authors:  A R Green; M V King; S E Shortall; K C F Fone
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

2.  The availability and depiction of synthetic cathinones (bath salts) on the Internet: Do online suppliers employ features to maximize purchases?

Authors:  Kathleen Meyers; Övgü Kaynak; Elena Bresani; Brenda Curtis; Ashley McNamara; Kristine Brownfield; Kimberly C Kirby
Journal:  Int J Drug Policy       Date:  2015-01-16

3.  Investigation of "bath salts" use patterns within an online sample of users in the United States.

Authors:  Patrick S Johnson; Matthew W Johnson
Journal:  J Psychoactive Drugs       Date:  2014 Nov-Dec

4.  Healthcare professionals are less confident in managing acute toxicity related to the use of new psychoactive substances (NPS) compared with classical recreational drugs.

Authors:  D M Wood; B Ceronie; P I Dargan
Journal:  QJM       Date:  2015-11-15

5.  Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus.

Authors:  Mariana Angoa-Pérez; Michael J Kane; Nieves Herrera-Mundo; Dina M Francescutti; Donald M Kuhn
Journal:  Life Sci       Date:  2013-07-24       Impact factor: 5.037

Review 6.  Synthetic cathinones: a new public health problem.

Authors:  Laurent Karila; Bruno Megarbane; Olivier Cottencin; Michel Lejoyeux
Journal:  Curr Neuropharmacol       Date:  2015-01       Impact factor: 7.363

Review 7.  Emerging drugs of abuse: current perspectives on substituted cathinones.

Authors:  Magalie Paillet-Loilier; Alexandre Cesbron; Reynald Le Boisselier; Joanna Bourgine; Danièle Debruyne
Journal:  Subst Abuse Rehabil       Date:  2014-05-26

Review 8.  Neurotoxicity Induced by Mephedrone: An up-to-date Review.

Authors:  Flaminia Pantano; Roberta Tittarelli; Giulio Mannocchi; Roberta Pacifici; Alessandro di Luca; Francesco Paolo Busardò; Enrico Marinelli
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

9.  Comprehensive review of the detection methods for synthetic cannabinoids and cathinones.

Authors:  Akira Namera; Maho Kawamura; Akihiro Nakamoto; Takeshi Saito; Masataka Nagao
Journal:  Forensic Toxicol       Date:  2015-03-06       Impact factor: 4.096

10.  Effect of Some Psychoactive Drugs Used as 'Legal Highs' on Brain Neurotransmitters.

Authors:  Krystyna Gołembiowska; Alexandra Jurczak; Katarzyna Kamińska; Karolina Noworyta-Sokołowska; Anna Górska
Journal:  Neurotox Res       Date:  2015-10-26       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.